Nucleoside Hydrolase NH 36: A Vital Enzyme for the Genus in the Development of T-Cell Epitope Cross-Protective Vaccines (Q64108190)

Europe PubMed Central

Purine metabolism in Leishmania donovani and Leishmania braziliensis

3 October 2022

cites work

1 reference

12 December 2020

A new approach to the phylogeny of Leishmania: species specificity of glycoconjugate ligands for promastigote internalization into murine macrophages

1 reference

12 December 2020

Inhibition of Leishmania donovani promastigote internalization into murine macrophages by chemically defined parasite glycoconjugate ligands

1 reference

12 December 2020

T-cell responses and immunity to experimental infection with leishmania major

1 reference

12 December 2020

Purine metabolism in Toxoplasma gondii

1 reference

12 December 2020

Purine salvage in Entamoeba histolytica

1 reference

12 December 2020

Purine-metabolising enzymes in Entamoeba histolytica

1 reference

12 December 2020

Enzymes of purine and pyrimidine metabolism from the human malaria parasite, Plasmodium falciparum

1 reference

12 December 2020

Leishmania donovani: titration of antibodies to the fucose-mannose ligand as an aid in diagnosis and prognosis of visceral leishmaniasis

1 reference

12 December 2020

Experimental murine Leishmania donovani infection: immunoprotection by the fucose-mannose ligand (FML)

1 reference

12 December 2020

Leishmania donovani surface glycoconjugate GP36 is the major immunogen component of the Fucose-Mannose Ligand (FML)

1 reference

12 December 2020

Purine-specific nucleoside N-ribohydrolase from Trypanosoma brucei brucei. Purification, specificity, and kinetic mechanism

1 reference

12 December 2020

The FML (Fucose Mannose Ligand) of Leishmania donovani. a new tool in diagnosis, prognosis, transfusional control and vaccination against human kala-azar

1 reference

12 December 2020

The logic of visceral leishmaniasis control

1 reference

12 December 2020

Prevalence of Anti-Leishmania donovani Antibody Among Brazilian Blood Donors and Multiply Transfused Hemodialysis Patients

1 reference

12 December 2020

Nucleoside hydrolase from Leishmania major. Cloning, expression, catalytic properties, transition state inhibitors, and the 2.5-å crystal structure

1 reference

12 December 2020

The fucose-mannose ligand-ELISA in the diagnosis and prognosis of canine visceral leishmaniasis in Brazil

1 reference

12 December 2020

A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (São Gonçalo do Amaranto, RN).

1 reference

12 December 2020

Vaccination of Balb/c mice against experimental visceral leishmaniasis with the GP36 glycoprotein antigen of Leishmania donovani

1 reference

12 December 2020

Protection against Leishmania donovani infection by DNA vaccination: increased DNA vaccination efficiency through inhibiting the cellular p53 response

1 reference

12 December 2020

Immunization with A2 protein results in a mixed Th1/Th2 and a humoral response which protects mice against Leishmania donovani infections

1 reference

12 December 2020

A nonspecific nucleoside hydrolase from Leishmania donovani: implications for purine salvage by the parasite

1 reference

12 December 2020

Nucleoside hydrolase from Leishmania (L.) donovani is an antigen diagnostic for visceral leishmaniasis.

1 reference

12 December 2020

The adenine phosphoribosyltransferase from Giardia lamblia has a unique reaction mechanism and unusual substrate binding properties

1 reference

12 December 2020

Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (S�o Gon�alo do Amarante, RN)

1 reference

12 December 2020

Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis

1 reference

12 December 2020

IgG1/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniosis

1 reference

12 December 2020

Genes of Bacillus cereus and Bacillus anthracis Encoding Proteins of the Exosporium

1 reference

12 December 2020

Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection.

1 reference

12 December 2020

Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity

1 reference

12 December 2020

Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine.

1 reference

12 December 2020

Cross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasis

1 reference

12 December 2020

Leishmune vaccine blocks the transmission of canine visceral leishmaniasis: absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs

1 reference

12 December 2020

Adoptive immunotherapy against experimental visceral leishmaniasis with CD8 T cells requires the presence of cognate antigen.

1 reference

12 December 2020

The FML-vaccine (Leishmune) against canine visceral leishmaniasis: a transmission blocking vaccine

1 reference

12 December 2020

Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis

1 reference

12 December 2020

Immunotherapy against visceral leishmaniasis with the nucleoside hydrolase-DNA vaccine of Leishmania donovani

1 reference

12 December 2020

Towards multilocus sequence typing of the Leishmania donovani complex: resolving genotypes and haplotypes for five polymorphic metabolic enzymes (ASAT, GPI, NH1, NH2, PGD).

1 reference

12 December 2020

Functional characterization of nucleoside transporter gene replacements in Leishmania donovani

1 reference

12 December 2020

Safety trial using the Leishmune vaccine against canine visceral leishmaniasis in Brazil.

1 reference

12 December 2020

Evolutionary and geographical history of the Leishmania donovani complex with a revision of current taxonomy

1 reference

12 December 2020

Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major

1 reference

12 December 2020

Immunotherapy against experimental canine visceral leishmaniasis with the saponin enriched-Leishmune vaccine

1 reference

12 December 2020

T-cell quality in memory and protection: implications for vaccine design

1 reference

12 December 2020

Structural basis for substrate specificity in group I nucleoside hydrolases

1 reference

12 December 2020

Purine and pyrimidine metabolism in Leishmania

1 reference

12 December 2020

FML vaccine against canine visceral leishmaniasis: from second-generation to synthetic vaccine

1 reference

12 December 2020

Immunogenicity assay of the Leishmune vaccine against canine visceral leishmaniasis in Brazil

1 reference

12 December 2020

Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein.

1 reference

12 December 2020

T-cell-derived cytokines, nitric oxide production by peripheral blood monocytes and seric anti-Leishmania (Leishmania) chagasi IgG subclass patterns following immunization against canine visceral leishmaniasis using Leishvaccine and Leishmune

1 reference

12 December 2020

Third-generation immucillins: syntheses and bioactivities of acyclic immucillin inhibitors of human purine nucleoside phosphorylase

1 reference

12 December 2020

Crystal structures of T. vivax nucleoside hydrolase in complex with new potent and specific inhibitors

1 reference

12 December 2020

Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune in Brazilian endemic areas

1 reference

12 December 2020

Advantages of a synthetic peptide immunogen over a protein immunogen in the development of an anti-pilus vaccine for Pseudomonas aeruginosa

1 reference

12 December 2020

The chimerical multi-component Q protein from Leishmania in the absence of adjuvant protects dogs against an experimental Leishmania infantum infection

1 reference

12 December 2020

Immunotherapy with the saponin enriched-Leishmune vaccine versus immunochemotherapy in dogs with natural canine visceral leishmaniasis.

1 reference

12 December 2020

Diminished CD4 /CD25 T cell and increased IFN-gamma levels occur in dogs vaccinated with Leishmune in an endemic area for visceral leishmaniasis

1 reference

12 December 2020

Adaptive immunity against Leishmania nucleoside hydrolase maps its c-terminal domain as the target of the CD4 T cell-driven protective response

1 reference

12 December 2020

One Health: the global challenge of epidemic and endemic leishmaniasis

1 reference

12 December 2020

Plasmodium falciparum parasites are killed by a transition state analogue of purine nucleoside phosphorylase in a primate animal model

1 reference

12 December 2020

Leishmaniasis worldwide and global estimates of its incidence

1 reference

12 December 2020

Immunobiology of visceral leishmaniasis

1 reference

12 December 2020

Cytokine responses to novel antigens in an Indian population living in an area endemic for visceral leishmaniasis

1 reference

12 December 2020

Structures of purine nucleosidase from Trypanosoma brucei bound to isozyme-specific trypanocidals and a novel metalorganic inhibitor

1 reference

12 December 2020

Comparison of two commercial vaccines against visceral leishmaniasis in dogs from endemic areas: IgG, and subclasses, parasitism, and parasite transmission by xenodiagnosis

1 reference

12 December 2020

Inhibition and Structure of Toxoplasma gondii Purine Nucleoside Phosphorylase

1 reference

12 December 2020

Metabolic reprogramming during purine stress in the protozoan pathogen Leishmania donovani

1 reference

12 December 2020

Cross-Protective Immunity to Leishmania amazonensis is Mediated by CD4 and CD8 Epitopes of Leishmania donovani Nucleoside Hydrolase Terminal Domains

1 reference

12 December 2020

Clinical and parasitological protection in a Leishmania infantum-macaque model vaccinated with adenovirus and the recombinant A2 antigen

1 reference

12 December 2020

Leishmania donovani Nucleoside Hydrolase Terminal Domains in Cross-Protective Immunotherapy Against Leishmania amazonensis Murine Infection

1 reference

12 December 2020

A randomised, double-blind, controlled efficacy trial of the LiESP/QA-21 vaccine in naïve dogs exposed to two leishmania infantum transmission seasons

1 reference

12 December 2020

Canine Leishmania vaccines: still a long way to go.

1 reference

12 December 2020

One-year timeline kinetics of cytokine-mediated cellular immunity in dogs vaccinated against visceral leishmaniasis

1 reference

12 December 2020

Immucillins Impair Leishmania (L.) infantum chagasi and Leishmania (L.) amazonensis Multiplication In Vitro

1 reference

12 December 2020

From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3 GLA-SE.

1 reference

12 December 2020

Immucillins ImmA and ImmH Are Effective and Non-toxic in the Treatment of Experimental Visceral Leishmaniasis

1 reference

12 December 2020

Regulation of immunity during visceral Leishmania infection

1 reference

12 December 2020

Status of vaccine research and development of vaccines for leishmaniasis

1 reference

12 December 2020

Vaccination against canine leishmaniosis increases the phagocytic activity, nitric oxide production and expression of cell activation/migration molecules in neutrophils and monocytes

1 reference

12 December 2020

Field randomized trial to evaluate the efficacy of the Leish-Tec® vaccine against canine visceral leishmaniasis in an endemic area of Brazil

1 reference

12 December 2020

Post-Genomics and Vaccine Improvement for Leishmania

1 reference

12 December 2020

Optimizing Immunization Strategies for the Induction of Antigen-Specific CD4 and CD8 T Cell Responses for Protection against Intracellular Parasites.

1 reference

12 December 2020

Multicomponent LBSap vaccine displays immunological and parasitological profiles similar to those of Leish-Tec® and Leishmune® vaccines against visceral leishmaniasis.

1 reference

12 December 2020

Expression, purification, immunogenicity and protective efficacy of a recombinant nucleoside hydrolase from Leishmania donovani, a vaccine candidate for preventing cutaneous leishmaniasis

1 reference

12 December 2020

The importance of nucleoside hydrolase enzyme (NH) in studies to treatment of Leishmania: A review

1 reference

12 December 2020

A Chimera Containing CD4 and CD8 T-Cell Epitopes of the Leishmania donovani Nucleoside Hydrolase (NH36) Optimizes Cross-Protection against Leishmania amazonesis Infection.

1 reference

12 December 2020

Combined virtual screening, MMPBSA, molecular docking and dynamics studies against deadly anthrax: An in silico effort to inhibit Bacillus anthracis nucleoside hydrolase.

1 reference

12 December 2020

Leishmania donovani Nucleoside Hydrolase (NH36) Domains Induce T-Cell Cytokine Responses in Human Visceral Leishmaniasis

1 reference

12 December 2020

3'nucleotidase/nuclease in protozoan parasites: Molecular and biochemical properties and physiological roles

1 reference

12 December 2020

The Immune Epitope Database: How Data Are Entered and Retrieved

1 reference

12 December 2020

F1 Domain of the Leishmania (Leishmania) donovani Nucleoside Hydrolase Promotes a Th1 Response in Leishmania (Leishmania) infantum Cured Patients and in Asymptomatic Individuals Living in an Endemic Area of Leishmaniasis

1 reference

12 December 2020

Field trial of efficacy of the Leish-tec® vaccine against canine leishmaniasis caused by Leishmania infantum in an endemic area with high transmission rates

1 reference

12 December 2020

Immucillins in Infectious Diseases

1 reference

12 December 2020

Evaluation of the Trypanosoma brucei 6-oxopurine salvage pathway as a potential target for drug discovery.

1 reference

12 December 2020

A large-scale field randomized trial demonstrates safety and efficacy of the vaccine LetiFend® against canine leishmaniosis.

1 reference

12 December 2020

NH36 and F3 Antigen-Primed Dendritic Cells Show Preserved Migrating Capabilities and CCR7 Expression and F3 Is Effective in Immunotherapy of Visceral Leishmaniasis.

1 reference

12 December 2020

Study of purinosome assembly in cell-based model systems with de novo purine synthesis and salvage pathway deficiencies

1 reference

12 December 2020

Cloning and characterisation of the Equilibrative Nucleoside Transporter family of Trypanosoma cruzi: ultra-high affinity and selectivity to survive in the intracellular niche

1 reference

12 December 2020